Cost-Effectiveness of Treatments for Adolescent Depression: Results From TADS
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: While the evidence base for treatments for adolescent depression is building, little is known about the relative efficiency of such treatments. Treatment costs are a relevant concern given the competing demands on family and health care budgets. The authors evaluated the cost-effectiveness of three active treatments among adolescents with major depressive disorder. METHOD: Volunteers (N=439) ages 12 to 18 with a primary diagnosis of major depressive disorder participated in a randomized, controlled trial conducted at 13 U.S. academic and community clinics from 2000 to 2004. Subjects included those participants who did not drop out and had evaluable outcome and cost data at 12 weeks (N=369). Subjects were randomly assigned to 12 weeks of either fluoxetine alone (10-40 mg/day), CBT alone, CBT combined with fluoxetine (10-40 mg/day), or placebo (equivalent to 10-40 mg/day). Both placebo and fluoxetine were administered double-blind; CBT alone and CBT in combination with fluoxetine were administered unblinded. Societal cost per unit of improvement on the Children's Depression Rating Scale-Revised and cost per quality-adjusted life year (QALY) were compared. RESULTS: Results ranged from an incremental cost over placebo of $24,000 per QALY for treatment with fluoxetine to $123,000 per QALY for combination therapy treatment. The cost-effectiveness ratio for CBT treatment was not evaluable due to negative clinical effects. The models were robust on a variety of assumptions. CONCLUSIONS: Both fluoxetine and combination therapy are at least as cost-effective in the short-term as other treatments commonly used in primary care (using a threshold of $125,000/QALY). Fluoxetine is more cost-effective than combination therapy after 12 weeks of treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More recently, initial research comparing behavior therapy and drug treatment has revealed that the combination of medication and non-drug treatment is the most effective in childhood depression, anxiety and obsessive-compulsive disorder (e.g., 33).”
From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [33]
Citations
Cites
Suicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054
Is there an epidemic of child or adolescent depression?
Jane Costello, E., Erkanli, A., & Angold, A. (2006) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2006.01682.x · Cited by 983
Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions
Fenwick, E., O'Brien, B. J., & Briggs, A. (2004) · Health Economics · doi:10.1002/hec.903 · Cited by 943
(2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1132 · Cited by 752
Self-citationWhat Is the Price of Life and Why Doesn't It Increase at the Rate of Inflation?
Ubel, P. A., Hirth, R. A., Chernew, M. E., & Fendrick, A. M. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.14.1637 · Cited by 588
Weisz, J. R., Jensen-Doss, A., & Hawley, K. M. (2006) · American Psychologist · doi:10.1037/0003-066x.61.7.671 · Cited by 560
Hoch, J. S., Briggs, A. H., & Willan, A. R. (2002) · Health Economics · doi:10.1002/hec.678 · Cited by 535
CURRY, J., ROHDE, P., SIMONS, A., SILVA, S., VITIELLO, B., KRATOCHVIL, C., REINECKE, M., FEENY, N., WELLS, K., PATHAK, S., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000240838.78984.e2 · Cited by 429
Self-citationEffective Treatment for Mental Disorders in Children and Adolescents
Burns, B. J., Hoagwood, K., & Mrazek, P. J. (1999) · Clinical Child and Family Psychology Review · doi:10.1023/a:1021826216025 · Cited by 385
Self-citation
Research works printed but not linked: 4
- Essau C, 1999, NJ, Jason Aronson, 69
- March J, JAMA 2004; 292: 807-820
- Gold MR, 1996, Russell LB
- Poznanski EO, 1996, Mokros HB: Children's Depression Rating Scale-Revised
Cited by
McMakin, D. L., Olino, T. M., Porta, G., Dietz, L. J., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Ryan, N. D., Birmaher, B., et al. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.01.011 · Cited by 448
Economics and mental health: the current scenario
Knapp, M., & Wong, G. (2020) · World Psychiatry · doi:10.1002/wps.20692 · Cited by 409
Cox, G. R., Callahan, P., Churchill, R., Hunot, V., Merry, S. N., Parker, A. G., & Hetrick, S. E. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008324.pub3 · Cited by 194
Therapist effectiveness: Implications for accountability and patient care
Kraus, D. R., Castonguay, L., Boswell, J. F., Nordberg, S. S., & Hayes, J. A. (2011) · Psychotherapy Research · doi:10.1080/10503307.2011.563249 · Cited by 192
ASARNOW, J. R., EMSLIE, G., CLARKE, G., WAGNER, K. D., SPIRITO, A., VITIELLO, B., IYENGAR, S., SHAMSEDDEEN, W., RITZ, L., BIRMAHER, B., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181977476 · Cited by 183
Self-citation
Metadata
- Authors
- Domino, M. E., Burns, B. J., Silva, S. G., Kratochvil, C. J., Vitiello, B., Reinecke, M. A., Mario, J., & March, J. S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Suburban Hospital (US)
- Venue
- American Journal of Psychiatry
- Published
- 2008-05
- Volume
- 165
- Issue
- 5
- Pages
- 588-596
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2121303532
- Cited by
- 92
- References
- 30
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 5 · 2017: 4 · 2016: 5 · 2015: 5 · 2014: 7 · 2013: 4 · 2012: 3
- FWCI
- 29.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- National Institutes of Health (n01mh080008-004)
- National Institute of Mental Health (N01 MH 80008, K01MH065639)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- adolescent depression, major depressive disorder, cost-effectiveness, fluoxetine, cognitive behavioral therapy, combination therapy, quality-adjusted life years, Children's Depression Rating Scale-Revised, treatment costs, primary care
- MeSH terms
- Adolescent, Child, Combined Modality Therapy, Cost-Benefit Analysis, Major Depressive Disorder, Drug Therapy, Female, Fluoxetine, Humans, Male, Primary Health Care, Psychotherapy, Treatment Outcome, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-Effectiveness of Treatments for Adolescent Depression: Results From TADS. https://app.cochat.ai/papers/10.1176/appi.ajp.2008.07101610
- The paper
- Domino, M. E., Burns, B. J., Silva, S. G., Kratochvil, C. J., Vitiello, B., Reinecke, M. A., Mario, J., & March, J. S. (2008). Cost-Effectiveness of Treatments for Adolescent Depression: Results From TADS. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2008.07101610
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.